The PM Society, a not-for-profit organisation that supports companies and individuals working in pharmaceutical marketing and healthcare communications, announced today that it has created
Once widely acknowledged as so special that only scientists and clinical specialists need to apply, oncology has become exponentially more clinically targeted and sophisticated over the las
As the digital era of communication continues to expand and flourish, the way life sciences companies interact with their customer is evolving rapidly.
There are three guiding principles that should underlie successful market segmentation, and therefore the success of a pharma brand. Phil Dunn explains the process.
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho